Civitas Therapeutics, Inc. — Form D

Civitas Therapeutics, Inc. of CHELSEA, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-08-29. The offering totals $55.3M, of which $55.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Glenn BatchelderDirectorCorcord, NH
David HirschDirectorSan Diego, CA
Rob HopfnerDirectorSan Diego, CA
Mark IwickiDirectorArlington, MA
BLAIR JACKSONDirectorCHELSEA, MA
Aidan KingDirectorDublin, L2
TIMOTHY S NELSONDirectorCHELSEA, MA
ROBERT S ROCHEDirectorCHELSEA, MA
RAJEEV S SHAHDirectorCHELSEA, MA
TIM S SHANNONDirectorCHELSEA, MA
RICHARD BATYCKYExecutive OfficerFRAMINGHAM, MA
Andrea FranzExecutive OfficerConcord, NH
MARTIN FREEDExecutive OfficerWALTHAM, MA
Mark IwickiExecutive OfficerArlington, MA
Bryan StuartExecutive OfficerCambridge, MA
Mary TaylorExecutive OfficerNeedham, MA
Timothy ShannonDirectorStamford, CT
Glenn BatchelderExecutive OfficerCorcord, NH
Rajeev P ShahDirectorChelsea, MA
Robert P HopfnerDirectorChelsea, MA
Robert P Roche, Jr.DirectorChelsea, MA

Other filings by this issuer (3)

FiledFormOfferingSold
2013-09-17D$38.3M$38.3M
2011-05-02D/A$28.6M$14.3M
2011-01-11D$20.0M$10.0M

More